A Trojan horse approach for efficient drug delivery in photodynamic therapy: focus on taxanes
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22330%2F23%3A43927190" target="_blank" >RIV/60461373:22330/23:43927190 - isvavai.cz</a>
Result on the web
<a href="https://pubs.rsc.org/en/content/articlelanding/2023/TB/D2TB02147A" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2023/TB/D2TB02147A</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d2tb02147a" target="_blank" >10.1039/d2tb02147a</a>
Alternative languages
Result language
angličtina
Original language name
A Trojan horse approach for efficient drug delivery in photodynamic therapy: focus on taxanes
Original language description
Photodynamic therapy is an effective method for the treatment of several types of cancerous and noncancerous diseases. The key to the success of this treatment method is effective drug delivery to the site of action, for instance, a tumor. This ensures not only the high effectiveness of the therapy but also the suppression of side effects. But how to achieve effective targeted delivery? Lately, much attention has been paid to systems based on the so-called Trojan horse model, which is gaining increasing popularity. The principle of this model is that the effective drug is hidden in the internal structure of a nanoparticle, liposome, or nanoemulsion and is released only at the site of action. In this review article, we focus on drugs from the group of mitotic poisons, taxanes, and their use with photosensitizers in combined therapy. Here, we discuss the possibilities of how to improve the paclitaxel and docetaxel bioavailability, as well as their specific targeting for use in combined photo- and chemotherapy. Moreover, we also present the state of the art multifunctional drugs based on cabazitaxel which, owing to a suitable combination with photosensitizers, can be used besides photodynamic therapy and also in photoacoustic imaging or sonodynamic therapy.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
<a href="/en/project/TH73020001" target="_blank" >TH73020001: Cancer immunotherapy: rejuvenation of anti-cancer response by immune checkpoint blockade using novel multifunctional nanoparticle to block CTLA-4 and eliminate ICER</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Materials Chemistry B
ISSN
2050-750X
e-ISSN
—
Volume of the periodical
Neuveden
Issue of the periodical within the volume
16 Mar 2023
Country of publishing house
GB - UNITED KINGDOM
Number of pages
17
Pages from-to
—
UT code for WoS article
001059896900001
EID of the result in the Scopus database
2-s2.0-85170213314